Drugmaker AbbVie succeeded in buying Shire on Friday in a $53 billion deal that will allow the U.S. company to slash its tax bill by reincorporating in Britain. AbbVie, which makes top-selling arthritis …
Drugmaker AbbVie succeeded in buying Shire on Friday in a $53 billion deal that will allow the U.S. company to slash its tax bill by reincorporating in Britain. AbbVie, which makes top-selling arthritis …